The Heart Research Discovery That Changed Men's Health

Some medicines are designed with surgical precision for exactly the job they end up doing. The compound at the heart of this story is not one of them. It was built to help struggling hearts, and it largely failed at that — yet the reason it failed turned out to be one of the most consequential accidents in modern pharmacology. It changed how millions of people talk to their doctors about something they had spent decades not mentioning.

It Started as a Heart Drug in a Small Kentish Town

The story begins in the late 1980s at Pfizer's European research site in Sandwich, a quiet town on the Kent coast. The scientists there were interested in new approaches to cardiovascular disease — angina, the crushing chest pain caused by narrowed coronary arteries, and high blood pressure.

Their thinking was elegant. Nitrate drugs, the traditional treatment for angina, work by boosting a signaling molecule called cyclic GMP, or cGMP. When cGMP rises inside the smooth muscle that lines your blood vessels, that muscle relaxes, the vessel widens, and blood flows more easily. But the body is careful with its signals. An enzyme called phosphodiesterase type 5 — usually shortened to PDE5 — exists specifically to break cGMP down again and switch the signal off.

So the Sandwich team asked a different question. Instead of adding more signal, what if you blocked the enzyme that erases it? Get in the way of PDE5, and whatever cGMP your body produces naturally would simply last longer. In 1989, chemists at the site synthesised a compound to test that idea. It was given the unglamorous internal code UK-92,480. Only later would the world know it as sildenafil.

The Side Effect Nobody Was Looking For

Early human trials ran in South Wales in the early 1990s, led by Pfizer clinical researcher Ian Osterloh. The results for angina were, by all accounts, disappointing. The compound was safe and it did relax blood vessels, but not nearly enough in the heart to justify pushing it forward as a cardiac drug. On paper, the program was heading for the shelf.

Then something odd showed up in the multiple-dose studies. Male volunteers began reporting unexpected erections. It would have been easy to file this away as a curiosity — but the team didn't. They recognized that an erection is fundamentally a blood-flow event, and that a drug which prolongs vessel relaxation in one part of the body might be doing something genuinely useful in another. At the time there was no effective oral option for erectile difficulty at all; the alternatives were injections, pellets and vacuum devices, and most men simply went without.

The program was redirected. The first published clinical data on sildenafil for erectile dysfunction appeared in 1996, and on 27 March 1998 the US Food and Drug Administration approved it under the brand name Viagra. It became the first oral treatment of its kind and, almost overnight, one of the most recognized medicines on earth. Pfizer's UK patent expired in 2013, and generic sildenafil has been widely available since. The cultural effect may have mattered as much as the clinical one: a condition that men had quietly endured for generations suddenly had a name, a mechanism and a conversation attached to it.

What Sildenafil Actually Does in the Body

Here is the part worth understanding properly, because it is widely misunderstood. Sexual arousal causes nerve endings and the lining of blood vessels in the penis to release nitric oxide. Nitric oxide switches on an enzyme called guanylate cyclase, which produces cGMP — the same messenger the Sandwich team were interested in. cGMP relaxes the smooth muscle in the arteries, blood rushes into the spongy tissue of the corpora cavernosa, the expanding tissue presses on the veins that would normally drain it, and the blood stays put. That is an erection, in plumbing terms.

PDE5 is highly concentrated in exactly that tissue, and its job is to break cGMP down and end the process. Sildenafil competes with cGMP for the enzyme's active site, so less cGMP is destroyed and the signal lasts longer.

Which leads to the single most important point in this article: sildenafil does not create desire and it does not start the process. It amplifies a signal that arousal has already produced. No arousal means no nitric oxide, no cGMP, and nothing for the drug to protect. It is an amplifier, not a switch.

A few practical consequences follow from the same chemistry. It generally takes somewhere between half an hour and an hour to take effect, and a large fatty meal slows absorption. The most common unwanted effects — headache, facial flushing, indigestion and a blocked nose — are all downstream of vessels relaxing in places you didn't particularly want them to. And the famous blue tinge to vision that some people notice comes from mild activity at PDE6, a closely related enzyme in the retina.

What It Is Actually Licensed For Today

Sildenafil citrate holds two main licensed indications, and the second one brings the story neatly back to where it began.

The first is erectile dysfunction. The landmark trial, published in the New England Journal of Medicine in 1998, followed 532 men and remains the reference point for everything that came after.

The second is pulmonary arterial hypertension — a serious condition in which the arteries carrying blood from the heart to the lungs become abnormally narrow and stiff, forcing the right side of the heart to work far harder than it should. PDE5 turns out to be plentiful in the pulmonary blood vessels too. Sold as Revatio, at a much lower dose taken three times daily rather than as needed, sildenafil was approved for this use following the SUPER-1 trial in 2005. In the European Union it is also licensed for children aged 1 to 17 with the condition. The molecule designed for the heart eventually found its cardiovascular purpose after all — just not the one anyone predicted.

Beyond those two licenses, sildenafil has been investigated in altitude-related lung problems, Raynaud's phenomenon and restricted growth in pregnancy. The honest summary is that results have been mixed, and one trial of sildenafil in pregnancy was halted early in the Netherlands over safety concerns in newborns. Repurposing a drug is a hypothesis, not a guarantee — and it's worth saying so plainly.

How You Get It, and Why That Still Matters

Access rules differ depending on where you live, and the differences are not trivial. In the UK, the Medicines and Healthcare products Regulatory Agency reclassified a 50 mg sildenafil tablet from prescription-only to pharmacy medicine in late 2017, and it reached pharmacy shelves in 2018. The UK was the first country in the world to do this. It can be supplied to men aged 18 and over after a conversation with a trained pharmacist; other strengths and generic sildenafil remain prescription-only. In the United States and Canada, sildenafil requires a prescription in all forms.

One of the regulator's stated reasons for the UK change was blunt: people were obtaining erectile dysfunction pills from illegal sources anyway, with no idea what was in them.

There are also genuine reasons this medicine sits behind a professional conversation. Sildenafil must never be combined with nitrate medicines, because together they can cause a dangerous drop in blood pressure. The same applies to riociguat, and caution is needed with certain blood pressure drugs. A pharmacist or doctor is checking for exactly this.

There is a final point that too often gets lost. Erectile difficulty is frequently an early signal of something happening in the blood vessels more broadly, and the small arteries involved tend to show strain before the larger ones in the heart do. For a meaningful number of men, this is the body raising a hand years before anything else does. That makes the conversation genuinely worth having — and it's a conversation a tablet cannot have for you.

The Science, in Brief

• Sildenafil citrate A selective inhibitor of the enzyme phosphodiesterase type 5 (PDE5). It works by slowing the breakdown of cyclic GMP, the signaling molecule that tells smooth muscle in blood-vessel walls to relax. The practical result is that vessels stay dilated for longer wherever PDE5 is active — principally the erectile tissue and the pulmonary arteries. It depends on an existing nitric oxide signal to act on, which is why it amplifies arousal rather than replacing it. It is a licensed medicine, not a supplement, and remains prescription-only in the US and Canada. Discussed here as pharmacology and medical history, not as a product recommendation.
• Nitric oxide The body's own vasodilator signal, released by nerve endings and the endothelial lining of blood vessels. It appears here because the mechanism is impossible to explain honestly without it — and because it clarifies why the story above is about amplifying a natural process rather than manufacturing one. This is physiology, not anything that can be bought.

The best thing about this story is not the punchline. It is what it says about the body: that biology rarely does only one thing at a time, that the same mechanism can show up in the heart, the lungs and the pelvis, and that some of the most useful discoveries arrive when someone pays attention to a result they were not looking for. If any of this feels relevant to you personally, the useful next step is not a search engine or a pill from an unfamiliar website. It's a proper conversation with a clinician who can look at the whole picture — including the parts that have nothing to do with the bedroom. This article is educational and is not a substitute for personalised medical advice.

This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for guidance from a qualified healthcare professional. Any medicine mentioned is discussed as science and medical history, not as a recommendation — never start, stop or combine any medication without speaking to a doctor or pharmacist, and never obtain prescription medicines from unregulated sources.